Product Information
PAROXETINE HCL 30 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0947 per EA under NDC 13107015690. Its NADAC has been published 611 times since Oct 15, 2014.
Strength
30 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107015690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA078406On Market Since
12/3/2009
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 30 MG TABLET has been published 611 times since Oct 15, 2014, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0947 per EA |
|---|---|
| All-time high | $0.1374 (Aug 10, 2022) |
| All-time low | $0.0735 (Nov 20, 2024) |
| 52-week high | $0.1098 |
| 52-week low | $0.0946 |
| Median price | $0.1145 |
| Average price | $0.1126 |
| Largest weekly change | +27.2% (Nov 22, 2023) |
| Weeks tracked | 611 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 30 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0947 per EA (NDC 13107015690), effective Jun 24, 2026.
How has the price of PAROXETINE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 30 MG TABLET has declined 26.6%. It has been tracked across 611 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 30 MG TABLET?
Since Oct 15, 2014, the NADAC for PAROXETINE HCL 30 MG TABLET has ranged from a low of $0.0735 (Nov 20, 2024) to a high of $0.1374 (Aug 10, 2022), with a median of $0.1145 per EA.
Are there cheaper alternatives to PAROXETINE HCL 30 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PAROXETINE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures PAROXETINE HCL 30 MG TABLET?
PAROXETINE HCL 30 MG TABLET (NDC 13107015690) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification